You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1226 to 1250 of about 5865
Next 25
05/23/2018
New Published Evidence for Deadly High-Grade Gliomas Linked to Improved Survival
05/22/2018
House approves `right to try,` sends bill to Trump`s desk
05/20/2018
Brain Tumor Awareness Month Webinar Series: Special Guest Dr Henry Friedman Tonight (Sunday 5/20/18) 7pm Eastern Time!
URGENT ACTIVISM ALERT: Right To Try Bill up for vote this Tuesday!
05/18/2018
Webinar: Navigating the New Normal After a Brain Cancer Diagnosis
Brain Tumor Awareness Month Seminar Series: Special Guest Dr Henry Friedman
House to vote on `right to try` bill next week
05/17/2018
Support for Legislation Increasing Awareness for DIPG
05/16/2018
Duane A. Mitchell, M.D., Ph.D., World-Renowned Immunotherapy Expert to Speak at Seattle “Brains Matter” Dinner
05/13/2018
Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
VA tightens oversight after outrage over conducting experiments on dogs, then killing them
When did the glioblastoma start growing, and how much time can be gained from surgical resection? A model based on the pattern of glioblastoma growth in vivo.
05/12/2018
Brain Tumor Awareness Week 2018 Webinar Series - Tonight! 7pm Eastern
05/09/2018
Brain Tumor Awareness Week 2018 Webinar Series - Date Change!
05/03/2018
Durham firm with innovative brain cancer treatment lights up $642K equity round
04/25/2018
Brain Tumor Awareness Week 2018 Webinar Series
04/24/2018
Needed context absent from release on “less toxic way to treat brain tumors”
Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas
04/19/2018
A Shock to the System: Tumor-Treating Fields Plus Temozolomide for Glioblastoma
04/18/2018
New Technology Crosses Blood-Brain Barrier To Fight Glioblastoma Cells Directly
Musella Foundation Copay assistance program is now closed to new and renewal patients
First-in-human evaluation of the Cleveland Multiport Catheter for convection-enhanced delivery of topotecan in recurrent high-grade glioma: results of pilot trial 1.
Validation of post-operative residual contrast enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma.
04/17/2018
Study Reports Possible Novel Method for Stopping Untreatable Pediatric Brain Cancer
Can all the money in the world beat cancer?